CHINA ITS (01900) announced its interim results, with a net profit attributable to shareholders of 27.2 million yuan, a decrease of 92.8% compared to the same period last year.
China Intelligent Transportation (01900) announced its mid-year results for 2026, achieving a revenue of 461 million yuan, a year-on-year increase of 32.2%. The profit attributable to owners of the parent company was 27.2 million yuan, a decrease of 92.8% compared to the previous year. Earnings per share were 0.02 yuan.
CHINA ITS (01900) announced its mid-term results for 2026, achieving revenue of 461 million yuan, a year-on-year increase of 32.2%. The profit attributable to the owners of the parent company was 27.2 million yuan, a year-on-year decrease of 92.8%. Earnings per share were 0.02 yuan.
The announcement stated that the decrease in profit was mainly due to the absence of a revaluation gain of approximately 350 million yuan recognized in the same period of 2025. This gain arose from the revaluation of the groups equity in FOREVEROPENSOURCE Information Technology Co., Ltd. to its fair value upon the group acquiring control of FOREVEROPENSOURCE on January 1, 2025.
Related Articles

KAISA GROUP (01638) announced its interim results, with a loss attributable to shareholders of approximately 9.3285 billion yuan, a year-on-year decrease of about 7%.

EDA GROUP HLDGS (02505) released its interim results, reporting a net loss attributable to shareholders of 42.16 million yuan, compared to a profit in the same period last year.

Gelin Biological (301688.SZ) stock will be listed on the ChiNext board on September 2.
KAISA GROUP (01638) announced its interim results, with a loss attributable to shareholders of approximately 9.3285 billion yuan, a year-on-year decrease of about 7%.

EDA GROUP HLDGS (02505) released its interim results, reporting a net loss attributable to shareholders of 42.16 million yuan, compared to a profit in the same period last year.

Gelin Biological (301688.SZ) stock will be listed on the ChiNext board on September 2.

RECOMMEND





